CClinicalTrials.gg
RecruitingNCT07090083Updated Sep 2, 2025

Pediatric Metabolic Dysfunction-associated Steatotic Liver Disease and Food Insecurity

An observational study in MASLD - Metabolic Dysfunction-Associated Steatotic Liver Disease and Food Insecurity, sponsored by University of California, San Francisco. Recruiting at 1 site in United States. Open to participants aged 6 Years to 17 Years. Per ClinicalTrials.gov, last updated 2025-09-02.

Sponsored by University of California, San Francisco · Observational

From the registry’s dates

  • Started Jul 2025; still recruiting 1 year 2 months later.
Study type
Observational
Model
Cohort
Time perspective
Cross-sectional
Enrollment
160
Ages
6 Years to 17 Years
Sex
All
01

Study summary

This proposal addresses a critical gap in our understanding of the impact of household food insecurity (FI) on pediatric metabolic dysfunction-associated steatotic liver disease (MASLD) severity. There is evidence that children in families that do not have the ability to provide consistently healthy and high-quality foods, such as fruits and vegetables, have worse diet quality that children in households that are food secure. Additionally, evidence from adult studies link household FI to MASLD and liver fibrosis, and prior research of the PI has shown that exposure to household FI in early childhood was associated with a nearly 4 times increased odds of pediatric MASLD in middle childhood. Possible mechanisms linking household FI to pediatric MASLD include lower intake of fruits and vegetables, higher intake of caloric dense nutrient poor foods (e.g., sugar sweetened beverages), and less diversity of foods. Given consensus recommendations for the management of MASLD focus on lifestyle modification, i.e., diet and exercise to achieve weight loss, this proposal seeks to explore the association of household FI and pediatric MASLD disease severity and whether those effects are mediated by dietary intake. Study participants include children/adolescents with MASLD who are receiving care at UCSF's liver clinic and Weight Management for Teen and Child Health (WATCH) Clinic, a pediatric subspecialty clinic.

Read the detailed description

Metabolic dysfunction-associated steatotic liver disease (MASLD) is now the most common type of chronic liver disease among children and adolescents in the US, with the highest burden among children from low-income families, those with obesity, and those who are Hispanic. MASLD describes a spectrum of liver injury from simple hepatic steatosis to steatohepatitis, which can progress to liver fibrosis, cirrhosis, hepatocellular carcinoma, and liver failure. MASLD is one of the leading indications for liver transplantation in adults. Emerging evidence in adults links household FI to MASLD, liver fibrosis, and mortality. FI is defined by the US Department of Agriculture (USDA) as a state in which there is "limited or uncertain availability of nutritionally adequate and safe foods or limited or uncertain ability to acquire foods in socially acceptable ways." Adults with MASLD and FI have been shown to have poor diet quality that is significantly associated with fibrosis.

Research has found that household FI is highly prevalent in families with children. Fifteen percent of U.S. households, and 30% of San Francisco households with children are food insecure, which limits the ability of these families to consistently provide healthy, high-quality food. Research has found that children living in food insecure households have worse diet quality with regard to specific food categories compared to those in food secure households. Specifically children in food insecure households consume fewer fruits and vegetables (F\&V), and more SSBs. Children in households with severe FI have worse overall diet quality than those who are food secure.

Researchers, including the PI (see preliminary studies below), have found that exposure to household FI in children/adolescents is associated with pediatric MASLD. Given current consensus recommendations for the management of pediatric MASLD focus on lifestyle interventions, i.e., diet and physical activity), this project will assess the association of household FI and MASLD disease severity and whether these effects are mediated by dietary intake.

02

Conditions studied

  • MASLD - Metabolic Dysfunction-Associated Steatotic Liver Disease
  • Food Insecurity

Keywords

  • MASLD
  • food insecurity
  • pediatric
03

In context

Lead sponsor

University of California, San Francisco is the lead sponsor of 2,132 studies on the registry; 375 are open to participants now.

Of its 262 completed or terminated interventional studies of FDA-regulated products, 196 (75%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
6 Years to 17 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Children with MASLD with and without exposure to household food insecurity.

Inclusion criteria

  • Children and adolescents receiving care in the liver and WATCH clinics.
  • Family living in California.
  • Parent/guardian speaks Spanish or English.
  • Child is between the ages of 6 to \<17 years.
  • Elevated ALT on at least 2 occasions within the past year:

    • ALT > 22 units/L for females.
    • ALT > 26 units/L for males.
  • BMI for age/sex ≥ 85%.
  • Alternatively, child has one elevated ALT within the past year and confirmed steatosis on imaging.
  • Family does not intend to move out of California within the next year.
  • Family is not already receiving EatSF SF Fruit and Vegetable Vouchers.
  • Family is not participating in any other dietary education programs besides those offered by the WATCH or liver clinics.

Exclusion criteria

Exclusion Criteria:

  • Child has an underlying condition or medication causing their weight gain (e.g., hypothyroidism, Prader-Willi syndrome, antipsychotic medications).
  • Child is on, or expected to go on, or starts on a weight loss medication (e.g., Qsymia or GLP-1 receptor agonists).
  • Child has another known cause of liver disease (not including MASLD or MASH), such as:

    • Autoimmune hepatitis.
    • Wilson's disease.
    • Hepatitis A, B, or C.
    • Acute infection.
    • Genetic condition causing inflammation in the liver.
05

Study design

Observational model
Cohort
Time perspective
Cross-sectional
Enrollment
160 participants (estimated)
Target follow-up
30 Days
Patient registry
Yes

Groups and cohorts

  • Food secure

    Children with MASLD with exposure to household food security

  • Food insecure

    Children with MASLD with exposure to household food insecurity

06

What researchers measure

Primary outcomes

  1. Alanine aminotransferase (ALT)

    Alanine aminotransferase (ALT)

    Time frame: 30 days

  2. Gamma-glutamyl transferase (GGT)

    Gamma-glutamyl transferase (GGT)

    Time frame: 30 days

Secondary outcomes

  1. Dietary intake of fruits and vegetables

    Dietary intake of fruit and vegetables

    Time frame: 30 days

  2. dietary intake of SSBs

    Dietary intake of sugar sweetened beverages

    Time frame: 30 days

07

Study locations

1 of 1 sites recruiting
  • University of California, San Francisco
    San Francisco, California 94158, United States
    • Sarah L Maxwell, MD · Contact · sarah.maxwell@ucsf.edu · 415-519-7863
    • Sarah L Maxwell, MD · Principal investigator
    Recruiting
08

References and documents

Publications

  • Golovaty I, Tien PC, Price JC, Sheira L, Seligman H, Weiser SD. Food Insecurity May Be an Independent Risk Factor Associated with Nonalcoholic Fatty Liver Disease among Low-Income Adults in the United States. J Nutr. 2020 Jan 1;150(1):91-98. doi: 10.1093/jn/nxz212. PubMed 31504710 ↗
  • Tamargo JA, Sherman KE, Campa A, Martinez SS, Li T, Hernandez J, Teeman C, Mandler RN, Chen J, Ehman RL, Baum MK. Food insecurity is associated with magnetic resonance-determined nonalcoholic fatty liver and liver fibrosis in low-income, middle-aged adults with and without HIV. Am J Clin Nutr. 2021 Mar 11;113(3):593-601. doi: 10.1093/ajcn/nqaa362. PubMed 33515016 ↗
  • Kardashian A, Dodge JL, Terrault NA. Food Insecurity is Associated With Mortality Among U.S. Adults With Nonalcoholic Fatty Liver Disease and Advanced Fibrosis. Clin Gastroenterol Hepatol. 2022 Dec;20(12):2790-2799.e4. doi: 10.1016/j.cgh.2021.11.029. Epub 2021 Dec 16. PubMed 34958747 ↗
  • Kardashian A, Dodge JL, Terrault NA. Racial and ethnic differences in diet quality and food insecurity among adults with fatty liver and significant fibrosis: a U.S. population-based study. Aliment Pharmacol Ther. 2022 Nov;56(9):1383-1393. doi: 10.1111/apt.17219. Epub 2022 Sep 29. PubMed 36173037 ↗
  • Landry MJ, van den Berg AE, Asigbee FM, Vandyousefi S, Ghaddar R, Davis JN. Child-Report of Food Insecurity Is Associated with Diet Quality in Children. Nutrients. 2019 Jul 12;11(7):1574. doi: 10.3390/nu11071574. PubMed 31336880 ↗
  • Maxwell SL, Price JC, Perito ER, Rosenthal P, Wojcicki JM. Food insecurity is a risk factor for metabolic dysfunction-associated steatotic liver disease in Latinx children. Pediatr Obes. 2024 Jun;19(6):e13109. doi: 10.1111/ijpo.13109. Epub 2024 Mar 7. PubMed 38453472 ↗

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 2, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07090083
Lead sponsor
University of California, San Francisco
Collaborators
American Gastroenterological Association Foundation, UCSF Population Health Health Equity Award
Responsible party
Sponsor
First posted
Jul 29, 2025
Start date
Jul 30, 2025
Primary completion
Dec 30, 2026 (estimated)
Completion
Dec 30, 2026 (estimated)
Last update
Sep 2, 2025

Study contacts

Milagro Escobar
Contact
milagro.escobar@ucsf.edu
415-519-7863
Sarah L Maxwell, MD
principal investigator · University of California, San Francisco

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion